319 related articles for article (PubMed ID: 26602814)
1. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains.
Khameneh B; Fazly Bazzaz BS; Amani A; Rostami J; Vahdati-Mashhadian N
Microb Pathog; 2016 Apr; 93():83-7. PubMed ID: 26602814
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
Vilchèze C; Kim J; Jacobs WR
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using
Genestet C; Ader F; Pichat C; Lina G; Dumitrescu O; Goutelle S
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061753
[TBL] [Abstract][Full Text] [Related]
4. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
[TBL] [Abstract][Full Text] [Related]
7. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
Guo N; Wu J; Fan J; Yuan P; Shi Q; Jin K; Cheng W; Zhao X; Zhang Y; Li W; Tang X; Yu L
Lett Appl Microbiol; 2014 Apr; 58(4):344-9. PubMed ID: 24330002
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
Ge F; Zeng F; Liu S; Guo N; Ye H; Song Y; Fan J; Wu X; Wang X; Deng X; Jin Q; Yu L
J Med Microbiol; 2010 May; 59(Pt 5):567-572. PubMed ID: 20075118
[TBL] [Abstract][Full Text] [Related]
10. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
[TBL] [Abstract][Full Text] [Related]
11. Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
Colangeli R; Jedrey H; Kim S; Connell R; Ma S; Chippada Venkata UD; Chakravorty S; Gupta A; Sizemore EE; Diem L; Sherman DR; Okwera A; Dietze R; Boom WH; Johnson JL; Mac Kenzie WR; Alland D;
N Engl J Med; 2018 Aug; 379(9):823-833. PubMed ID: 30157391
[TBL] [Abstract][Full Text] [Related]
12. Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
Macingwana L; Baker B; Ngwane AH; Harper C; Cotton MF; Hesseling A; Diacon AH; van Helden P; Wiid I
J Antimicrob Chemother; 2012 Dec; 67(12):2908-11. PubMed ID: 22875849
[TBL] [Abstract][Full Text] [Related]
13. Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
Barbosa AR; Caleffi-Ferracioli KR; Leite CQ; García-Ramos JC; Toledano-Magaña Y; Ruiz-Azuara L; Siqueira VL; Pavan FR; Cardoso RF
Chemotherapy; 2016; 61(5):249-55. PubMed ID: 26950478
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides.
Pospisilova S; Kos J; Michnova H; Kapustikova I; Strharsky T; Oravec M; Moricz AM; Bakonyi J; Kauerova T; Kollar P; Cizek A; Jampilek J
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087309
[No Abstract] [Full Text] [Related]
15. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
[TBL] [Abstract][Full Text] [Related]
16. Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico.
Amaya-Tapia G; Martín-Del Campo L; Aguirre-Avalos G; Portillo-Gómez L; Covarrubias-Pinedo A; Aguilar-Benavides S
Microb Drug Resist; 2000; 6(2):143-5. PubMed ID: 10990269
[TBL] [Abstract][Full Text] [Related]
17. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.
Cavalieri SJ; Biehle JR; Sanders WE
Antimicrob Agents Chemother; 1995 Jul; 39(7):1542-5. PubMed ID: 7492101
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
[TBL] [Abstract][Full Text] [Related]
20. Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism.
Piana A; Orrù M; Masia MD; Sotgiu G; Muresu E; Maida A
New Microbiol; 2003 Oct; 26(4):375-81. PubMed ID: 14596348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
